Electroconvulsive Therapy in a Patient With a Liver Transplant.

Area of Science:

• Transplantation Medicine
• Psychiatry
• Gastroenterology

Background:

• Depression is a significant complication following liver transplantation, potentially jeopardizing graft survival and patient life.
• Severe depression requires effective treatment, but its management in liver transplant recipients is sparsely reported.
• Electroconvulsive therapy (ECT) is a proven, safe, and effective treatment for severe depression.

Purpose of the Study:

• To evaluate the safety and efficacy of electroconvulsive therapy (ECT) in a patient with severe major depression who previously underwent liver transplantation.
• To assess the impact of ECT on graft viability and overall patient well-being post-liver transplant.

Main Methods:

• Case report of a patient with a history of orthotopic liver transplant 26 years prior.
• Administration of an index course of electroconvulsive therapy (ECT) for severe major depression.
• Monitoring for complications related to the liver graft and general health.

Main Results:

• The patient tolerated the electroconvulsive therapy (ECT) course well.
• The patient demonstrated a robust response to ECT, with significant improvement in depressive symptoms.
• No complications pertinent to the liver graft or other adverse events were observed.

Conclusions:

• Liver transplantation is not a contraindication for electroconvulsive therapy (ECT).
• Clinicians should consider ECT as a viable treatment option for severe depression in liver transplant recipients when indicated.
• ECT can be safely administered to patients with a history of liver transplantation without compromising graft function.